These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 24064012

  • 1. Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.
    Na SY, Park MJ, Park S, Lee ES.
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):32-40. PubMed ID: 24064012
    [Abstract] [Full Text] [Related]

  • 2. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
    Hamzaoui K, Kaabachi W, Fazaa B, Zakraoui L, Mili-Boussen I, Haj-Sassi F.
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
    [Abstract] [Full Text] [Related]

  • 3. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
    Lucherini OM, Lopalco G, Cantarini L, Emmi G, Lopalco A, Venerito V, Vitale A, Iannone F.
    Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
    [Abstract] [Full Text] [Related]

  • 4. Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease.
    Ahmadi M, Yousefi M, Abbaspour-Aghdam S, Dolati S, Aghebati-Maleki L, Eghbal-Fard S, Khabbazi A, Rostamzadeh D, Alipour S, Shabani M, Nouri M, Babaloo Z.
    J Cell Physiol; 2019 Apr; 234(4):3985-3994. PubMed ID: 30317557
    [Abstract] [Full Text] [Related]

  • 5. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.
    Chi W, Zhu X, Yang P, Liu X, Lin X, Zhou H, Huang X, Kijlstra A.
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3058-64. PubMed ID: 18579762
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-37 expression is decreased in Behçet's disease and is associated with inflammation.
    Bouali E, Kaabachi W, Hamzaoui A, Hamzaoui K.
    Immunol Lett; 2015 Oct; 167(2):87-94. PubMed ID: 26253248
    [Abstract] [Full Text] [Related]

  • 7. Skewed TGFβ/Smad signalling pathway in T cells in patients with Behçet's disease.
    Shimizu J, Izumi T, Arimitsu N, Fujiwara N, Ueda Y, Wakisaka S, Yoshikawa H, Kaneko F, Suzuki T, Takai K, Suzuki N.
    Clin Exp Rheumatol; 2012 Oct; 30(3 Suppl 72):S35-9. PubMed ID: 22935165
    [Abstract] [Full Text] [Related]

  • 8. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
    Deniz R, Tulunay-Virlan A, Ture Ozdemir F, Unal AU, Ozen G, Alibaz-Oner F, Aydin-Tatli I, Mumcu G, Ergun T, Direskeneli H.
    Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
    [Abstract] [Full Text] [Related]

  • 9. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.
    Shimizu J, Takai K, Fujiwara N, Arimitsu N, Ueda Y, Wakisaka S, Yoshikawa H, Kaneko F, Suzuki T, Suzuki N.
    Clin Exp Immunol; 2012 Apr; 168(1):68-74. PubMed ID: 22385240
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-28A promotes IFN-γ production by peripheral blood mononuclear cells from patients with Behçet's disease.
    Li B, Xie C, Lin X, Su SB.
    Cell Immunol; 2014 Jul; 290(1):116-9. PubMed ID: 24973639
    [Abstract] [Full Text] [Related]

  • 11. Elevated levels of interleukin-27 and effect on production of interferon-γ and interleukin-17 in patients with Behçet's disease.
    Shen H, Xia LP, Lu J.
    Scand J Rheumatol; 2013 Jul; 42(1):48-51. PubMed ID: 23101722
    [Abstract] [Full Text] [Related]

  • 12. Decreased interleukin 27 expression is associated with active uveitis in Behçet's disease.
    Wang C, Tian Y, Ye Z, Kijlstra A, Zhou Y, Yang P.
    Arthritis Res Ther; 2014 May 28; 16(3):R117. PubMed ID: 24887071
    [Abstract] [Full Text] [Related]

  • 13. IL-18 mRNA expression and IFN-gamma induction in bronchoalveolar lavage from Behçet's disease.
    Hamzaoui A, Ghraïri H, Ammar J, Zekri S, Guemira F, Hamzaoui K.
    Clin Exp Rheumatol; 2003 May 28; 21(4 Suppl 30):S8-14. PubMed ID: 14727452
    [Abstract] [Full Text] [Related]

  • 14. Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease.
    Sugi-Ikai N, Nakazawa M, Nakamura S, Ohno S, Minami M.
    Invest Ophthalmol Vis Sci; 1998 May 28; 39(6):996-1004. PubMed ID: 9579479
    [Abstract] [Full Text] [Related]

  • 15. Association of Reduced Heme Oxygenase-1 with Decreased MicroRNA-196a2 Expression in Peripheral Blood Mononuclear Cells of Patients with Intestinal Behcet's Disease.
    Zou J, Ji DN, Shen Y, Guan JL, Zheng SB.
    Ann Clin Lab Sci; 2016 Dec 28; 46(6):675-679. PubMed ID: 27993883
    [Abstract] [Full Text] [Related]

  • 16. Effect of Interferon alfa-2a Treatment on Adaptive and Innate Immune Systems in Patients With Behçet Disease Uveitis.
    Albayrak O, Oray M, Can F, Uludag Kirimli G, Gul A, Tugal-Tutkun I, Onal S.
    Invest Ophthalmol Vis Sci; 2019 Jan 02; 60(1):52-63. PubMed ID: 30601931
    [Abstract] [Full Text] [Related]

  • 17. Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet's disease.
    Liu X, Wang C, Ye Z, Kijlstra A, Yang P.
    Invest Ophthalmol Vis Sci; 2013 Sep 05; 54(9):6012-7. PubMed ID: 23908180
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-26 is overexpressed in Behçet's disease and enhances Th17 related -cytokines.
    Kaabachi W, Bouali E, Berraïes A, Dhifallh IB, Hamdi B, Hamzaoui K, Hamzaoui A.
    Immunol Lett; 2017 Oct 05; 190():177-184. PubMed ID: 28811236
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-155 regulates the Th17 immune response by targeting Ets-1 in Behçet's disease.
    Na SY, Park MJ, Park S, Lee ES.
    Clin Exp Rheumatol; 2016 Oct 05; 34(6 Suppl 102):S56-S63. PubMed ID: 27156371
    [Abstract] [Full Text] [Related]

  • 20. IFN-alpha blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease.
    Liu X, Yang P, Wang C, Li F, Kijlstra A.
    Rheumatology (Oxford); 2011 Feb 05; 50(2):293-8. PubMed ID: 21059671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.